Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

FHS
June 13, 2024
1:13 pm

The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the Francis Crick Institute and AstraZeneca.

Researchers probe environmental causes of preterm birth with $2.8M grant

A new grant will help Wayne State University researchers explore the links between bacterial infections, the environmental factors that increase their susceptibility and the risk

October 4, 2024

Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because — you know what we are

February 26, 2024

Incyte advances its Opzelura eczema campaign with a ‘reimagine’ theme

Incyte’s newest campaign for Opzelura (ruxolitinib) encourages itchy patients to “Reimagine Relief” as it works to carve out a niche in the crowded eczema treatment

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.